Inst Diagnosti (Chile) Performance
| INDISA Stock | CLP 1,591 0.60 0.04% |
On a scale of 0 to 100, Inst Diagnosti holds a performance score of 20. The company retains a Market Volatility (i.e., Beta) of -0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Inst Diagnosti are expected to decrease at a much lower rate. During the bear market, Inst Diagnosti is likely to outperform the market. Please check Inst Diagnosti's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Inst Diagnosti's current trending patterns will revert.
Risk-Adjusted Performance
20 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Inst Diagnosti are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Inst Diagnosti sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 15.1 B | |
| Total Cashflows From Investing Activities | -32.7 B |
Inst |
Inst Diagnosti Relative Risk vs. Return Landscape
If you would invest 145,310 in Inst Diagnosti on September 20, 2024 and sell it today you would earn a total of 13,750 from holding Inst Diagnosti or generate 9.46% return on investment over 90 days. Inst Diagnosti is generating 0.2798% of daily returns and assumes 1.0631% volatility on return distribution over the 90 days horizon. Simply put, 9% of stocks are less volatile than Inst, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Inst Diagnosti Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inst Diagnosti's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inst Diagnosti, and traders can use it to determine the average amount a Inst Diagnosti's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2632
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | INDISA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.06 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.26 actual daily | 20 80% of assets perform better |
Based on monthly moving average Inst Diagnosti is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inst Diagnosti by adding it to a well-diversified portfolio.
Inst Diagnosti Fundamentals Growth
Inst Stock prices reflect investors' perceptions of the future prospects and financial health of Inst Diagnosti, and Inst Diagnosti fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inst Stock performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0489 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 329.99 B | |||
| Shares Outstanding | 140.93 M | |||
| Price To Earning | 18.54 X | |||
| Price To Book | 2.28 X | |||
| Price To Sales | 1.21 X | |||
| Revenue | 188.54 B | |||
| EBITDA | 28.05 B | |||
| Cash And Equivalents | 18.3 B | |||
| Cash Per Share | 129.85 X | |||
| Total Debt | 33.85 B | |||
| Debt To Equity | 69.60 % | |||
| Book Value Per Share | 722.14 X | |||
| Cash Flow From Operations | 14.83 B | |||
| Earnings Per Share | 135.00 X | |||
| Total Asset | 230.88 B | |||
About Inst Diagnosti Performance
By analyzing Inst Diagnosti's fundamental ratios, stakeholders can gain valuable insights into Inst Diagnosti's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Inst Diagnosti has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Inst Diagnosti has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Instituto de Diagnstico S.A. provides healthcare services in various medical specialties and sub-specialties in Chile. The company was founded in 1961 and is based in Providencia, Chile. INST DIAGNOSTICO is traded on Commodity Exchange in Exotistan.Things to note about Inst Diagnosti performance evaluation
Checking the ongoing alerts about Inst Diagnosti for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inst Diagnosti help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company has 33.85 Billion in debt which may indicate that it relies heavily on debt financing | |
| About 33.0% of the company shares are held by company insiders |
- Analyzing Inst Diagnosti's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inst Diagnosti's stock is overvalued or undervalued compared to its peers.
- Examining Inst Diagnosti's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inst Diagnosti's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inst Diagnosti's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inst Diagnosti's stock. These opinions can provide insight into Inst Diagnosti's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Inst Stock analysis
When running Inst Diagnosti's price analysis, check to measure Inst Diagnosti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inst Diagnosti is operating at the current time. Most of Inst Diagnosti's value examination focuses on studying past and present price action to predict the probability of Inst Diagnosti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inst Diagnosti's price. Additionally, you may evaluate how the addition of Inst Diagnosti to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |